Breathing Techniques, Asthma Control Level, Asthma in Children, Asthma Patients, Breathing Exercise
Conditions
Keywords
Asthma, Buteyko, breathing retraining, pediatrics
Brief summary
This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.
Interventions
BEHAVIORALButeyko
The Buteyko breathing exercise is a method that encourages nasal breathing, reducing breathing volume, and using breath-holding exercises to normalize breathing pattern
DRUGAsthma reliever and controller
Asthma reliever and controller according to GINA (Global Initiative for Asthma) guideline
Sponsors
Fakultas Kedokteran Universitas Indonesia
Dr Cipto Mangunkusumo General Hospital
Ivan Sofian Wibowo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
1. Children aged 7-17 years 2. Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score \> 1) 3. Receive bronchodilator therapy, either oral or inhaler from a pediatrician. 4. Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form. 5. Can understand instructions.
Exclusion criteria
1. Inpatients 2. Have received Buteyko breathing exercises or other breathing exercises. 3. Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders. 4. Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises. 5. Have contraindications for spirometry examination
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Asthma control | At enrollment and end of fourth-week | Level of asthma control measured by Asthma Control Questionnaire (ACQ) - Indonesian version. Minimum value 0, maximum value 6. Higher score means worse outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bronchodilator use | At end of fourth-week | Bronchodilator use measured by logbook, recorded by caregiver of patients |
| FEV1 | At enrollment and end of fourth-week | Forced Expiratory Volume in one second reflects degree of airway obstruction. Measured by spirometry. |
| FVC | At enrollment and end of fourth-week | Forced Vital Capacity is total volume of air that can forcefully exhale after taking the deepest possible breath. Measured by spirometry. |
| Asthma Quality of Life | At enrollment and end of fourth-week | Measured by Pediatric Asthma Quality of Life Questionnaire standardized version (PAQLQ(S)) - Indonesian version. Minimum value 1, maximum value 7. Higher scores means better outcome. |
| PEFR | At enrollment and end of fourth-week | Peak Expiratory Flow Rate is maximum speed (flow rate) of air that can be blowed out in a single forced breath. Measured by spirometry. |
| Control Pause | At enrollment and end of fourth-week | Duration of control pause |
| FEV1/FVC | At enrollment and end of fourth-week | Ratio of Forced Expiratory Volume in 1 second (FEV₁) to the Forced Vital Capacity (FVC). Measured by spirometry. |
Countries
Indonesia
Contacts
Primary ContactIvan S Wibowo, Medical Doctor
Outcome results
None listed